Mark Oldham

Mark Oldham is Professor of Radiation Oncology and Professor of Physics at Duke University, where he also serves as Director of the Duke Medical Physics MS/PhD Graduate Program and is a Member of the Duke Cancer Institute. His academic career spans over three decades with progressive appointments from Instructor to full Professor in Radiation Oncology.

Dr. Oldham received his Ph.D. from Newcastle University (United Kingdom) in 1991. His research interests focus on innovative approaches to radiation therapy, particularly FLASH radiation therapy using the Duke High Intensity Gamma Source (HIGS), radiation and immunotherapy utilizing mini-grids, Radiation Therapy Enhanced by Cherenkov photo-Activation (RECA), and comprehensive 3D dosimetry systems. His work has been recognized with multiple Paper of the Year awards from SEAAPM and the prestigious Farrington Daniel Award from AAPM.

His recent publications demonstrate a strong focus on 3D dosimetry systems, radiation therapy verification techniques, and novel cancer treatment approaches. His research integrates advanced dosimetry methods with innovative radiation therapy techniques to improve cancer treatment outcomes. His work on polymer gel dosimetry, optical CT scanning, and radiation-immunotherapy combinations represents cutting-edge developments in the field.

Dr. Oldham's scientific achievements have been recognized through multiple awards including the Paper of the Year (2018, 2017), Farrington Daniel Award (2016, 2002), Excellence in Teaching (2014), Excellence in Mentoring (2011), and Fellow of the AAPM (2010). He has also received the Director's Award for Exemplary Service multiple times.

As a principal investigator and co-investigator, Dr. Oldham has secured significant research funding from the National Institutes of Health, National Institute of Dental and Craniofacial Research, and Ian's Friends Foundation. His current research portfolio includes exploring synthetic lethality with high energy electron FLASH radiation beams, super-FLASH therapy for pediatric brain tumors, and radiation protection mechanisms. He serves on the Board of Directors of the American Association of Medical Physics and has made significant contributions to medical physics education through his leadership of Duke's Medical Physics Graduate Program.